January 30, 2008

By Susan Shepherd The New York Times

August 15, 2007

The public sector has a key role in drug R&D. Patenting minor changes to extend monopoly prices spells misuse By Dr. Brian Druker

May 23, 2007

By Dr. Tido von Schoen-Angerer Executive director Access to Essential Medicines Campaign Doctors Without Borders

May 16, 2007

Dr. Buddhima Lokuge U.S. manager, Access to Essential Medicines Campaign

April 12, 2007

By David Wilson Medical Coordinator, Doctors Without Borders/Médecins Sans Frontieres

March 09, 2007

By Dr. Richard Rockefeller Chairman, Doctors Without Borders/Médecins Sans Frontières (MSF) Board of Advisors

February 27, 2007

By Dr. Jean-Hervé Bradol President, Médecins Sans Frontières

May 24, 2006

By Rowan Gillies and Ellen 'T hoen

May 01, 2006

By Nicolas De Torrenté, Executive Director of MSF-USA

January 19, 2006

By Milton Tectonidis, M.D.

Pages